M. MALIK & col
510
7.
World Health Organization, How to Investigate Drug Use in Health Facilities: Selected
Drug Use Indicators: Action Programme on Essential Drugs 1993: World Health
Organization.
8.
Ghaffar, A., Kazi, B.M. and Salman, M. (2000) Health care systems in transition III.
Pakistan, Part I. An overview of the health care system in Pakistan. Journal of Public
Health, 22(1): 38-‐42
9.
Rational Pharmaceutical Management Plus Program, Pharmaceutical Management for
Malaria, USAD, Editor 2004, U.S. Agency for International Development: USA.
10.
Obinna, O., Kaur,H., Dike, E., Shu,E., Uzochukwu,B., Hanson,K., Okoye,V. and Okonkwo,P.
et al., (2009). Malaria treatment perceptions, practices and influences on provider
behaviour: comparing hospitals and non-‐hospitals in south-‐east Nigeria. Mal.,J., 8: 246-‐.
doi:10.1186/1475-‐2875-‐8-‐22
11.
Chitaka, R.,. Khare, A.K and Brickling, C. (1998). Prescribing policy for antimalarials. .
African Health, 20(2): 2-‐5.
12.
Das, N., Baloch H. Khan, A. NBadini, Z. A. Parkash,J. et al., (2001). Prescribing practices
of consultants at Karachi, Pakistan. Journal-‐Pakistan Medical Association, 51(2): 74-‐77.
13.
Elhassan, A.M.S.A.(1999). Prescribing and dispensing practice at NGO, govemment.and
private clinics in Nepalguni municipality. Nepal INRUD News 9: 25-‐26.
14.
Igboeli, N.U., Ukwe, C.V. and Ekwunife, O.I. (2010). Increasing use of artemisinin-‐based
combination therapy for treatment of malaria infection in Nigerian hospitals. Pharmacy
Practice (Internet), 8(4): 243-‐249.
15.
Yousif, M.A. and Adeel, A.A. (2000). Antimalarials prescribing patterns in Gezira State:
precepts and practices. Eastern Mediterranean Health Journal, 15(5/6):. 939-‐947.
16.
Adibe, M.O.(2010). Predictors to adherence to national anti-‐malarial treatment
guidelines in some Nigerian hospitals. Inter.J Drug Development and Research, 2(3):
545-‐554.
